Aqaba Container Terminal signs agreement with King Hussein Cancer Foundation
Titled "Awareness is Power," ACT will support the foundation in delivering awareness lectures and community outreach activities for breast cancer awareness and early detection services, targeting underprivileged women in Aqaba. ACT will cover the cost of mammogram vouchers, and the initiative will be implemented through home visits and by facilitating the transfer of eligible women to undergo mammogram screenings.
Under the agreement, King Hussein Cancer Foundation will train 25 volunteers in breast cancer knowledge and communication. The program will also deliver 400 awareness sessions reaching 6,000 women in Aqaba, in addition to hosting a public event reaching 200 members of the community and referring at least 100 women for mammograms.
Commenting on this agreement, Harald Nijhof, Chief Executive Officer of Aqaba Container Terminal, said, "At ACT, it is a deeply rooted value of ours to contribute to the quality of life of the communities we work in. Partnering with the King Hussein Cancer Foundation reflects our commitment to sustainable development in Aqaba, where economic growth is paired with investment in health, education, and opportunity. We are proud to stand with KHCF in empowering women with knowledge and access to early detection services that save lives."
Mrs. Nisreen Qatamish, CEO and Director General of the King Hussein Cancer Foundation, said, "We are honored to partner with Aqaba Container Terminal on this vital initiative that will directly impact the lives of women in southern Jordan. Early detection remains our strongest weapon against breast cancer, and through ACT's generous support, we can ensure that geographic location and financial circumstances do not determine a woman's access to potentially life-saving screenings. This collaboration exemplifies how private sector leadership can drive meaningful change in public health outcomes, and we look forward to expanding this model of community-centered care throughout the region."
It is worth noting that Aqaba Container Terminal's support of KHCF's project builds upon long-term collaborations with the foundation. The terminal has been dedicated for 9 years in support of improving cancer treatment services in Jordan's southern governorates. ACT has also generously donated to the King Hussein Cancer Center and has a building named after the terminal. Through initiatives like these, ACT continues to demonstrate its dedication to advancing the health and well-being of the communities it serves.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economy ME
a day ago
- Economy ME
Jordan sees record growth in medical tourism with over 92,000 visitors by May 2025
Jordan is solidifying its status as the Middle East and North Africa (MENA) region's leading medical tourism destination, recording a remarkable rise in patient arrivals seeking both advanced medical care and natural therapeutic treatments. During the first seven months of 2025, the country witnessed a record increase in medical tourist arrivals, building on steady growth over the past three years. In 2024, over 224,000 medical tourists visited Jordan — up from 202,592 in 2023 and 191,532 in 2022 — demonstrating consistent upward momentum. The growth is powered by two major factors: An expanding range of specialized healthcare services, supported by a highly skilled medical workforce, and the country's natural healing environments like the Dead Sea and Ma'in Hot Springs. Jordan has an expanding range of specialized healthcare services, supported by a highly skilled medical workforce Read: UAE leads in accredited healthcare facilities globally, allocates $1.57 billion for 2025 services A booming global industry Jordan's growth in medical tourism comes amid a global surge in demand for cross-border healthcare . The global medical tourism market, valued at $31.23 – 41.79 billion in 2024, is projected to reach over $160 billion by 2032. The MENA region, particularly GCC countries, has traditionally been a major source of outbound medical travelers. Kuwait sends around 650 patients per month abroad, incurring $1 billion annually, while Saudi Arabia's Health Ministry reported 2,400 patients treated overseas, costing $800 million. Jordan's ability to attract these outbound patients has transformed the country into a regional hub for inbound medical tourism, generating over $1 billion in annual revenue, which contributes approximately 4 percent to Jordan's GDP. 'Our medical tourism sector has a legacy that dates back to the 1970s, when Jordan emerged as one of the top destinations for medical care in the region. The sector is continuing to demonstrate exceptional growth as a preferred therapeutic destination both regionally and globally,' said Dr. Abdelrazzak Arabiyat, managing director of the Jordan Tourism Board. 'The growth in medical tourism is primarily driven by the world-class healthcare services that our hospitals offer, the popularity of the natural therapeutic sites and the renowned hospitality of our country. 'What sets the country's medical tourism sector apart are the cost-effective yet high quality care assured within the country and the diverse natural attractions that add to the well-being of the patients and those who accompany them,' Dr. Arabiyat added. Record-breaking visitor numbers in 2025 In just the first quarter of 2025, Jordan welcomed 51,448 medical tourists, which rose to 92,776 by the end of May, marking a 16.5 percent increase compared to the same period last year. The country is on track to surpass previous records and set a new benchmark for its healthcare tourism sector. Jordan continues to attract patients primarily from Iraq, Saudi Arabia, Palestine, Syria, Yemen, Libya, and other GCC countries, drawn by the nation's quality healthcare, affordability, and cultural proximity. Jordan's growth in medical tourism comes amid a global surge in demand for cross-border healthcare World-class healthcare at competitive prices Jordan's medical care offers substantial cost advantages. Treatments are estimated to be 25 percent to 40 percent cheaper than in the US and Europe, and 5 percent to 10 percent lower than in medical tourism leaders like India, Singapore, and Thailand. The country boasts over 120 hospitals and medical centers, including 71 private and 47 public institutions. Many of these are internationally accredited by bodies such as the Joint Commission International (JCI) and the Health Care Accreditation Council (HCAC), assuring high standards of care and patient safety. Advanced medical capabilities and historic milestones Jordan has been a medical pioneer in the region, performing the first open-heart surgery in 1970 and the first kidney transplant in 1972. The King Hussein Cancer Center (KHCC) remains one of the region's most advanced oncology institutions, completing 250 bone marrow transplants in 2022 with a success rate of over 85 percent, matching international benchmarks. Top hospitals attracting medical tourists include: Jordan Hospital Specialty Hospital Abdali Hospital Al-Kindi Hospital Ibn Al-Haytham Hospital Arab Medical Center King Hussein Cancer Center In the public sector, leading institutions include Royal Medical Services (Medical City) and Al-Bashir Hospital. The country's medical workforce exceeds 30,000 professionals, many of whom are Western-educated and board-certified, offering services in specialties like cardiology, oncology, orthopedics, and fertility. Short waiting times and the widespread use of English among medical professionals further enhance patient confidence and comfort. Natural therapeutic destinations Complementing Jordan's medical infrastructure are unique natural healing sites that support patient recovery: Dead Sea: The lowest point on Earth (400 meters below sea level), offering mineral-rich waters with 33 percent salt content known for treating skin, joint, and respiratory conditions. Ma'in Hot Springs: Featuring thermal waterfalls up to 60°C, known for benefits in treating skin disorders, arthritis, and circulatory issues. These natural resources offer a distinctive recovery experience that combines modern medicine with ancient therapeutic traditions. What sets Jordan's medical tourism sector apart are the cost-effective yet high quality care Strong economic contribution Medical tourism is a significant pillar of Jordan's economy, not only generating over $1 billion annually but also creating thousands of jobs and supporting related sectors such as hospitality, transport, and translation services. Medical tourists are estimated to spend 3 to 5 times more than leisure travelers due to longer stays and broader service needs. Jordan's well-developed hospitality infrastructure, with accommodation options, patient transport, and multilingual support, ensures a smooth experience for international patients and their companions. 'The diversity of medical specialties available in Jordan, combined with our natural therapeutic destinations and skilled healthcare professionals, has created a strong and sustainable medical tourism ecosystem,' Dr Arabiyat said. 'Over the years, we have been focused on promoting our strengths in medical tourism through targeted digital ad campaigns, promotional videos and FAM trips for media and medical delegations, all contributing to the popularity of the country for world-class medical care.' As demand for global healthcare options grows, Jordan is well-positioned to lead the MENA region in offering high-quality, affordable, and holistic medical care. Backed by robust infrastructure, medical expertise, and natural therapeutic advantages, the country continues to elevate its reputation as a premier global medical tourism destination.
Zawya
a day ago
- Zawya
Jordan takes prime position as MENA's medical tourism destination with strong growth in international visitors
Specialized treatments and world-class healthcare facilities drive sector growth Natural therapeutic destinations complement advanced medical services and world-class clinicians and professionals Amman, Jordan: Jordan is taking the prime position as the Middle East and North Africa region's leading medical tourism destination, with record growth in visitor arrivals for specialized medical care and natural therapy during the first seven months of 2025. This builds on the over 224,000 medical tourists who visited Jordan last year, recording a consistent growth in numbers – from 191,532 in 2022 and 202,592 in 2023. The growth is supported by two key drivers: One, the increase in specialized healthcare offerings backed by an expert pool of clinicians and healthcare professionals; and two, the natural offerings of the country that serve to soothe the body and mind. Today, the global medical tourism market is witnessing significant growth, with valuations ranging from USD 31.23 billion to USD 41.79 billion in 2024, and projections indicating expansion to over USD 160 billion by 2032. The MENA region, particularly the GCC countries, has historically been a significant source of outbound medical tourists. According to estimates, Kuwait alone sends approximately 650 patients monthly for overseas treatment, with annual costs reaching about 1 billion USD, while Saudi Arabia's Health Ministry reported 2,400 patients treated abroad at a cost of US$ 800 million. Against this backdrop, Jordan has emerged as a premier medical tourism destination in the MENA region, generating more than 1 billion USD in revenue annually and accounting for approximately 4% of the nation's GDP. Having welcomed over 51,448 medical tourists in the first quarter of 2025, which increased to 92,776 by the end of May, a growth of 16.5% over the same period last year, Jordan's medical tourism sector is set to achieve a new milestone this year. Jordan's appeal as a medical tourism destination is particularly strong among Gulf Cooperation Council (GCC) nations and neighboring countries. A significant portion of the annual medical tourists are from countries such as Iraq, Saudi Arabia, Palestine, Syria, Yemen, Libya, and other Gulf nations. "Our medical tourism sector has a legacy that dates back to the 1970s, when Jordan emerged as one of the top destinations for medical care in the region. The sector is continuing to demonstrate exceptional growth as a preferred therapeutic destination both regionally and globally," said Dr. Abdelrazzak Arabiyat, Managing Director of the Jordan Tourism Board. The country's notable milestones in the healthcare sector include conducting the first open-heart surgery in 1970, followed by the first kidney transplant in 1972. The King Hussein Cancer Center (KHCC) has reported significant medical achievements, including 250 bone marrow transplants in 2022 alone, with success rates exceeding 85%, on par with international rates. "The growth in medical tourism is primarily driven by the world-class healthcare services that our hospitals offer, the popularity of the natural therapeutic sites and the renowned hospitality of our country. What sets the country's medical tourism sector are the cost-effective yet high quality care assured within the country and the diverse natural attractions that add to the well-being of the patients and those who accompany them,' added Dr. Arabiyat. According to estimates, a primary draw for international medical visitors is the substantial cost savings offered. Treatment prices in Jordan are reported to be about 25% to 40% less than those in the United States and Europe, and even 5% to 10% lower than in other prominent medical tourism hubs such as India, Singapore, and Thailand. A robust healthcare infrastructure Jordan's healthcare ecosystem is world-class with over 120 hospitals and medical centers, including 71 private and 47 public health institutions. Many of these facilities have prestigious international accreditations from organizations such as the Joint Commission International (JCI) and the Health Care Accreditation Council (HCAC). This provides peace of mind to medical tourists that they are assured of the highest standards of patient care and safety. Jordan Hospital, Specialty Hospital, Abdali Hospital, Al-Kindi Hospital, Ibn Al-Haytham Hospital, Arab Medical Center and King Hussein Cancer Center are leading names in the private sector, while Royal Medical Services (Medical City) and Al-Bashir Hospital are among the top choices in the public sector for medical tourists. Another strength of the country is its medical workforce of more than 30,000 professionals, many of them Western-educated and board-certified, who deliver specialized treatments ranging from advanced cardiac procedures and cancer care to orthopedic surgeries and fertility treatments. The absence of considerable waiting lists for procedures and the widespread availability of English-speaking medical staff and surgeons contribute substantially to patient convenience and confidence. Complementing the country's advanced medical facilities are unique natural therapeutic sites that enhance patient recovery and wellness. The Dead Sea, 400 meters below sea level, provides exceptional therapeutic benefits through its mineral-rich waters containing 33% salt content. Ma'in Hot Springs, with mineral-rich waters reaching temperatures of 60°C, is renowned for its therapeutic benefits for skin conditions, joint pain, and circulatory problems. Contribution to the national economy Medical tourism contributes significantly to the country's national income, providing thousands of job opportunities and supports many related sectors. It is estimated that a medical tourist spends 3 to 5 times more than a regular tourist due to extended stays. The country's hospitality infrastructure is well positioned to support the sector with a diverse range of accommodation facilities for patients and their companions. Other conveniences include ease of transportation with pickup and drop-off services, and translation services provided in multiple languages with support from specialized offices and companies. "The diversity of medical specialties available in Jordan, combined with our natural therapeutic destinations and skilled healthcare professionals, has created a strong and sustainable medical tourism ecosystem," added Dr. Arabiyat. "Over the years, we have been focused on promoting our strengths in medical tourism through targeted digital ad campaigns, promotional videos and FAM trips for media and medical delegations, all contributing to the popularity of the country for world-class medical care." For more information about medical tourism in Jordan, visit About Jordan Tourism Board The Jordan Tourism Board (JTB) was launched in March 1998 as an independent, public-private sector partnership committed to utilize marketing strategies to brand, position and promote the Jordan tourism product as the destination of choice in the international markets. The adopted strategies are tuned to reflect the true image of the Jordan tourism product, being a cultural, natural, religious, adventurous, leisure and MICE destination. As part of its marketing strategies, the JTB plans and executes an integrated program of international promotional activities. This program includes the active participation in trade fairs, trade workshops, trade and consumer road shows, familiarization trips, press trips, brochure & multimedia production, and media relations. To carry out its goals, the Jordan Tourism Board utilizes the services of eleven offices in Europe and N. America. For more details, visit:
Zawya
4 days ago
- Zawya
HOPE Foundation and Taiwan's Top Lung Cancer Experts Call for Seamless Integration of Early Screening, Precision Diagnostics, and Early Treatment
TAIPEI, TAIWAN - Media OutReach Newswire - 16 August 2025 - Lung cancer continues to be the leading cause of cancer-related deaths worldwide. Yet, progress is within reach. In Taiwan, thanks to the National Lung Cancer Early Detection Program, the proportion of early-stage lung cancer cases continues to rise. Against this backdrop, HOPE Foundation for Cancer Care, one of the largest cancer-focused patient advocacy groups in Taiwan, recently hosted a press conference titled "Healthy Taiwan, Leading the World – Ushering in a New Era of Early Screening and treatment of Lung Cancer". The event brought together distinguished government officials, ten leading medical authorities in lung cancer, and renowned lung cancer experts from major medical centers nationwide to chart the next phase of early lung cancer prevention and control policies. United in their commitment, participants advocated for the seamless integration of early screening, precision diagnostics, and early treatment in lung cancer care, strengthening efforts to promote early detection and intervention. Ultimately, aiming to support Taiwan in achieving its ambitious goal of reducing cancer mortality rates by one-third by 2030, setting a new international benchmark in cancer control. Taiwan's proactive approach to lung cancer prevention is recognized globally for its vision and effectiveness. In July 2022, the government launched the Lung Cancer Early Detection Program, offering biannual low-dose CT (LDCT) screenings for high-risk groups, including those with a family history of lung cancer and heavy smokers. This pioneering initiative has positioned Taiwan as an international role model in lung cancer prevention. Over the past three years, more than 210,000 screenings have led to the identification of 2,506 lung cancer cases—over 80% of which were diagnosed at an early stage, with late-stage diagnoses dropping sevenfold. Previously, late-stage diagnosis was the norm, but Taiwan's proactive policies have transformed the landscape, reversing the trend and ensuring that most initial lung cancer cases are now detected early. During his recent visit to Taiwan, Dr. Cary Adams, CEO of the Union for International Cancer Control (UICC), commended Taiwan's National Cancer Control Program, its comprehensive cancer registry, and robust National Health Insurance (NHI) system for establishing an exemplary cancer care network. He encouraged Taiwan to further improve early lung cancer screening rates and timely access to treatment, reinforcing its status as a global public health leader. At the conference, Minister of Health and Welfare Dr. Chiu Tai-Yuan pledged ongoing cross-ministerial collaboration and policy innovation to improve early lung cancer detection and treatment. Legislator Wang Cheng-Hsu also reaffirmed his commitment to early detection and intervention, advocating for increased resources and improved legislation to ensure early-stage lung cancer patients receive comprehensive care. Leading medical experts further emphasized Taiwan's advancements. Dr. Yang, Pan-Chyr, Academician of Academia Sinica, highlighted how the LDCT screening program has driven a shift toward earlier-stage diagnosis, with research indicating it could reduce lung cancer mortality by 53%. Dr. Chen Chien-Jen, Academician of Academia Sinica emphasized that the next key challenge is ensuring early-stage patients benefit from precision diagnostics and early treatment. Dr. Yang Cheng-Ta, President of the Taiwan Lung Cancer Society, added that emerging AI technology is now capable of analyzing LDCT images to predict an individual's six-year cancer risk, which will improve identification of high-risk groups and support early intervention. Dr. Yang Chih-Hsin, President of Taiwan Association for the Study of Lung Cancer, urged early-stage patients to undergo genetic testing promptly, enabling medical teams to tailor optimal treatment plans, including surgery, targeted therapy, or immunotherapy as adjuvant treatments. HOPE called for NHI resources to shift toward early lung cancer diagnosis and treatment, highlighting the importance of genetic testing and adjuvant therapy for high-risk early-stage patients to reduce relapse and mortality. Clinical evidence shows that adjuvant targeted therapy after surgery for stage IB–IIIA lung cancer with EGFR mutations can reduce five-year mortality by 10%, which is vital for improving outcomes and easing the burden on the healthcare system. Dr. Chen Jin-Shing, Head of Thoracic Surgery Division at National Taiwan University Hospital, advocated for priority reimbursement of adjuvant targeted therapy for patients with stage IB-IIIA lung cancer, while Dr. Chen Chih-Yi, Board Member of HOPEemphasized the importance of improving access to early genetic testing and treatment. Dr. Huang, Ming-Shyan, President of the Taiwan Clinical Oncology Society, pointed out that early-stage lung cancer treatment in Taiwan is not yet fully aligned with international guidelines, and urged that expanded screening must be matched with optimized NHI resource allocation and improved treatment access. Other leading voices reinforced the need for comprehensive care. Dr. Wang Chin-Chou, Board Member of Taiwan Society of Pulmonary and Critical Care Medicine, stressed that while surgery is the primary treatment for early-stage lung cancer, it must be accompanied by proactive adjuvant therapy strategies and long-term follow-up. Dr. Chang Wen-Cheng, CEO of Taiwan Cancer Foundation emphasized that the integration of screening, diagnosis, and treatment is crucial to truly realize early detection and treatment, as well as maximizing the value of screening program. Dr. Chen Jen-Shi, President of Taiwan Oncology Society, recommended that in addition to current NHI and Cancer Drug Fund financing, the government should promote diverse payment mechanisms—such as co-payment models or commercial insurance to supplement the NHI system—to further improve access to early lung cancer treatment. Uniting multiple lung cancer treatment experts from medical centers across Taiwan, a concerted effort to usher in a new era of early lung cancer screening and treatment. (Listed by institution from North to South) · Dr. Chen Yu-Min, Director of General Chest Medicine Department, Taipei Veterans General Hospital · Dr. Lee Kang-Yun, Attending Physician, Division of Pulmonary Medicine, Shuang Ho Hospital · Dr. Huang Chun-Yao, Attending Physician, Division of Chest Medicine, Taipei Tzu Chi Hospital · Dr. Tsai Chen-Liang, Director of Pulmonary and Critical Care Medicine Division, Tri-Service General Hospital · Dr. Yeh Yu-Wen, Physician, Division of Thoracic Medicine, Shin Kong Wu Ho-Su Memorial Hospital · Dr. Chang Sheng-Yu, Attending Physician and Leader of the Lung Cancer Team, Far Eastern Memorial Hospital · Dr. Yang Tsung-Ying, Director of General Chest Medicine Department, Taichung Veterans General Hospital · Dr. Hsia Te-Chun, Deputy Director, Department of Internal Medicine, China Medical University Hospital · Dr. Lin Chien-Chung, Attending Physician, Division of Chest Medicine, National Cheng Kung University Hospital Hashtag: #HOPEFoundation The issuer is solely responsible for the content of this announcement. Hope Foundation For Cancer Care
